Ocular Therapeutix Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Ocular Therapeutix Inc
TickerOCUL
CIK #0001393434
CUSIP67576A100
SectorLife Sciences - Pharmaceutical Preparations
Address36 Crosby Drive Suite 101, Bedford, MA 01730
Source [EDGAR]
CIK Filing 2011 - 2024
[0001393434] 10-K
[0001393434] 10-Q
[0001393434] 3
[0001393434] 4
[0001393434] 8-K
[0001393434] D
[0001393434] SC 13D
[0001393434] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Ocular Therapeutix Inc [2022-02-10] 5.32
BlackRock Inc Ocular Therapeutix Inc [2021-02-02] 7.3
Man Group PLC Ocular Therapeutix Inc [2019-05-31] 5.74
Opaleye Management Inc Ocular Therapeutix Inc [2019-05-03] 11.0
Summer Road LLC Ocular Therapeutix Inc [2019-03-04] 17.8
BlackRock Inc Ocular Therapeutix Inc [2019-02-08] 6.8
FMR LLC Ocular Therapeutix Inc [2018-02-12] 0.0
Summer Road LLC Ocular Therapeutix Inc [2018-02-07] 8.4
Summer Road LLC Ocular Therapeutix Inc [2018-02-07] 8.4
Prudential Financial Inc Ocular Therapeutix Inc [2016-07-11] 12.0
Jennison Associates LLC Ocular Therapeutix Inc [2016-07-08] 12.0
Ascension Health Ventures II LLC Ocular Therapeutix Inc [2016-02-12] 0.0
Capital World Investors Ocular Therapeutix Inc [2016-02-12] 8.2
Federated Investors Inc /PA/ Ocular Therapeutix Inc [2016-02-11] 6.66
Capital Research Global Investors Ocular Therapeutix Inc [2015-07-10] 11.5
FMR LLC Ocular Therapeutix Inc [2015-06-10] 0.0
Versant Side Fund III LP Ocular Therapeutix Inc [2015-02-17] 0.1
Wellington Management Group LLP Ocular Therapeutix Inc [2015-02-12] 6.08
CHV II LP Ocular Therapeutix Inc [2015-02-10] 9.849
Polaris Venture Partners V LP Ocular Therapeutix Inc [2014-08-11] 11.9
SVLSF IV LLC Ocular Therapeutix Inc [2014-08-05] 12.6
Khosravi Farhad Ocular Therapeutix Inc [2014-08-04] 5.4
Sawhney Amarpreet Ocular Therapeutix Inc [2014-08-04] 13.4
Form 3/4/5 Filer 2011 - 2024
Ocular Therapeutix Inc
Notman Donald
Mattessich Antony C.
Strassburger Philip C.
White Christopher G
Ozden Rabia Gurses
Summer Road LLC
Heier Jeffrey S.
Lindstrom Richard L MD
Warden Charles M
Williams Leslie J.
Raines Merilee
Hong Seung Suh
Goldstein Michael H.
Peacock Bruce
Kitchen Patricia
Opaleye Management Inc.
Sawhney Amarpreet
Bollag Daniel M
Hanley Kevin F.
Oshea William J
Chadha Jaswinder
Garvey James M
Migausky George V
Hurley Charles Andrew
Talamo Jonathan H.
Fortune James
Ankerud Eric
Smith W Bradford
Versant Venture Capital III, L.P.
Versant Side Fund III, L.P.
SVLSF IV LLC
SV Life Sciences Fund IV Strategic Partners L P
SV Life Sciences Fund IV (GP), L.P.
SV Life Sciences Fund IV LP
Polaris Venture Partners Special Founders' Fund V, L.P.
Polaris Venture Partners V, L.P.
Polaris Venture Partners Founders' Fund V, L.P.
Polaris Venture Management Co. V, L.L.C.
Polaris Venture Partners Entrepreneurs' Fund V, L.P.
Ascension Health Ventures II, LLC
CHV II LP
Crane Alan L
Form 13F Holdings
Firm Period DFND Voting Shares
Summer Road LLC [2023-03-31] DFND 6,122,089.0 6,122,089.0
Opaleye Management Inc [2023-03-31] SOLE 6,105,900.0 6,105,900.0
BlackRock Inc. [2023-03-31] SOLE 4,884,541.0 4,918,309.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 3,895,751.0
Citadel Advisors LLC [2023-03-31] DFND 1,975,072.0 1,975,072.0
Deltec Asset Management LLC [2023-03-31] SOLE 1,913,612.0 1,913,612.0
State Street Corp [2023-03-31] DFND 1,413,595.0 1,492,959.0
Geode Capital Management LLC [2023-03-31] DFND 1,457,740.0 1,457,740.0
Morgan Stanley [2023-03-31] DFND 1,071,739.0 1,181,703.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 1,099,770.0 1,099,770.0
Millennium Management LLC [2023-03-31] SOLE 1,036,555.0 1,036,555.0
Susquehanna International Group LLP [2023-03-31] DFND 244,579.0 713,179.0
Northern Trust Corp [2023-03-31] DFND 31,768.0 657,097.0
Cetera Investment Advisers [2023-03-31] SOLE 0.0 601,150.0
Endurant Capital Management LP [2023-03-31] SOLE 512,744.0 512,744.0
UBS OConnor LLC [2023-03-31] DFND 363,286.0 363,286.0
Two Sigma Investments LP [2023-03-31] SOLE 323,424.0 323,424.0
Two Sigma Advisers LP [2023-03-31] SOLE 243,100.0 309,400.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 307,108.0
Knoll Capital Management, LLC [2023-03-31] SOLE 295,800.0 295,800.0
Bank of New York Mellon Corp [2023-03-31] DFND 260,699.0 290,055.0
Barclays PLC [2023-03-31] SOLE 279,687.0 279,687.0
Banco Santander, S.A. [2023-03-31] DFND 267,889.0 267,889.0
Levin Capital Strategies LP [2023-03-31] OTR 0.0 207,624.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 206,249.0 206,249.0
Ikarian Capital LLC [2023-03-31] SOLE 200,000.0 200,000.0
Nottingham Advisors Inc [2023-03-31] SOLE 0.0 194,266.0
Nuveen Asset Management LLC [2023-03-31] DFND 193,033.0 193,033.0
Goldman Sachs Group Inc [2023-03-31] DFND 180,605.0 180,665.0
Royal Bank of Canada [2023-03-31] DFND 180,001.0 180,001.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com